Viewing Study NCT03048461


Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2026-02-26 @ 2:16 AM
Study NCT ID: NCT03048461
Status: WITHDRAWN
Last Update Posted: 2021-12-23
First Post: 2017-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
Sponsor: Northwestern University
Organization:

Study Overview

Official Title: A Randomized, Double-blind, Placebo-controlled Clinical Trial Investigating the Effect of Autologous Platelet-rich Plasma in Subjects With Androgenetic Alopecia.
Status: WITHDRAWN
Status Verified Date: 2021-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Did not want to enroll and proceed with this study concept.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of androgenetic alopecia.

This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with moderate androgenetic alopecia. Approximately 30 subjects will be randomized into the study. The study is designed as an 18-month study consisting of 2 phases. This study was a pilot study designed to determine feasibility of this procedure.

Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: